Prosecution Insights
Last updated: November 20, 2026
Application No. 18/037,570

DEVICES FOR CELL OR TISSUE CULTURING, OR TESTING IN VITRO MUSCLE TISSUE

Final Rejection §103
Filed
May 18, 2023
Priority
Nov 25, 2020 — EU 20209706.9 +3 more
Examiner
KRCHA, MATTHEW D
Art Unit
1796
Tech Center
1700 — Chemical & Materials Engineering
Assignee
Koninklijke Philips N.V.
OA Round
2 (Final)
64%
Grant Probability
Moderate
3-4
OA Rounds
0m
Est. Remaining
99%
With Interview

Examiner Intelligence

Grants 64% of resolved cases
64%
Career Allowance Rate
372 granted / 577 resolved
-0.5% vs TC avg
Strong +36% interview lift
Without
With
+35.5%
Interview Lift
resolved cases with interview
Typical timeline
3y 3m
Avg Prosecution
61 currently pending
Career history
662
Total Applications
across all art units

Statute-Specific Performance

§101
1.8%
-38.2% vs TC avg
§103
51.9%
+11.9% vs TC avg
§102
17.8%
-22.2% vs TC avg
§112
25.5%
-14.5% vs TC avg
Black line = Tech Center average estimate • Based on career data from 577 resolved cases

Office Action

§103
DETAILED ACTION Notice of Pre-AIA or AIA Status The present application, filed on or after March 16, 2013, is being examined under the first inventor to file provisions of the AIA . Response to Amendment The Amendment filed on 10/2/2026 has been entered. Claims 1-17 remain pending in the application. Applicant’s amendments to the claims have overcome each and every 112(b) rejection previously set forth in the non-final Office Action mailed 5/5/2026. Claim Rejections - 35 USC § 103 In the event the determination of the status of the application as subject to AIA 35 U.S.C. 102 and 103 (or as subject to pre-AIA 35 U.S.C. 102 and 103) is incorrect, any correction of the statutory basis (i.e., changing from AIA to pre-AIA ) for the rejection will not be considered a new ground of rejection if the prior art relied upon, and the rationale supporting the rejection, would be the same under either status. The following is a quotation of 35 U.S.C. 103 which forms the basis for all obviousness rejections set forth in this Office action: A patent for a claimed invention may not be obtained, notwithstanding that the claimed invention is not identically disclosed as set forth in section 102, if the differences between the claimed invention and the prior art are such that the claimed invention as a whole would have been obvious before the effective filing date of the claimed invention to a person having ordinary skill in the art to which the claimed invention pertains. Patentability shall not be negated by the manner in which the invention was made. The factual inquiries for establishing a background for determining obviousness under 35 U.S.C. 103 are summarized as follows: 1. Determining the scope and contents of the prior art. 2. Ascertaining the differences between the prior art and the claims at issue. 3. Resolving the level of ordinary skill in the pertinent art. 4. Considering objective evidence present in the application indicating obviousness or nonobviousness. This application currently names joint inventors. In considering patentability of the claims the examiner presumes that the subject matter of the various claims was commonly owned as of the effective filing date of the claimed invention(s) absent any evidence to the contrary. Applicant is advised of the obligation under 37 CFR 1.56 to point out the inventor and effective filing dates of each claim that was not commonly owned as of the effective filing date of the later invention in order for the examiner to consider the applicability of 35 U.S.C. 102(b)(2)(C) for any potential 35 U.S.C. 102(a)(2) prior art against the later invention. Claim(s) 1-8, 16 and 17 is/are rejected under 35 U.S.C. 103 as being unpatentable over United States Application Publication No. 2014/0220555, hereinafter Chen in view of United States Application Publication No. 2007/0212775, hereinafter Cohen. Regarding claim 1, Chen teaches a device made of elastomeric material (paragraph [0051]) for culturing in vitro muscle tissue (intended use MPEP § 2114 (II)), the device comprising: a base section (the bottom of item 240); two pillars (items 260a and 260b) each protruding from the base section (figure 2); and a wall section (the walls of item 240) with an inner wall surface surrounding the pillars (figure 2), and an outer wall surface (figure 2), wherein the device is configured to be received in a well of a microwell plate (functional limitation (MPEP § 2114) and the base and walls with the two pillars would be able to be received by a well of a microwell plate). Chen fails to teach the wall section comprises at least two rib elements extending outwardly from the outer wall surface to an outer periphery of the device. Cohen teaches a microtiter plate which has four ribs (Cohen, items 12 and 14) on each of the middle wells of the device (Cohen, figure 2) so that the plate can be reinforced while also a considerable portion of the well to contact a sample holder (Cohen, paragraph [0017]). It would have been obvious to one having ordinary skill in the art before the effective filing date of the claimed invention to have added four ribs which extend outwardly from the outer wall surface to an outer periphery of the device because it would allow for the device to be reinforced while also a considerable portion of the well to contact a sample holder (Cohen, paragraph [0017]). Regarding claim 2, modified Chen teaches the wall section comprises at least three rib elements extending in at least two non-parallel directions within a virtual plane comprising the base section (see supra). Regarding claim 3, Chen teaches the inner wall surface has a non- unity aspect ratio (paragraph [0056]). Regarding claim 4, Chen teaches the height of the rib elements is less than or equal to the height of the wall section (paragraph [0056]) and wherein the height of the wall section is less than or equal to 2000µm (paragraph [0056]). Regarding claim 5, Chen teaches the height of the pillar is less than 2 mm tall (paragraph [0057]). Chen fails to specifically teach the height of the pillars is greater than or equal to 500µm and less than or equal to 2000µm. The claimed range overlaps or falls within the prior art range; in cases where the claimed range overlaps or falls within the prior art range, a prima facie case of obviousness of the range exists. It would have been obvious to one having ordinary skill in the art to have selected the portion of the height of the pillars in the range that corresponds to the claimed range. See MPEP 2144.05(I). Regarding claim 6, Chen teaches the Young's Modulus of the material used to manufacture the pillars is 1-10 MPa. Chen fails to specifically teach the Young's Modulus of the material used to manufacture the pillars is greater than or equal to 0.5 MPa and less than or equal to 5 MPa. The claimed range overlaps or falls within the prior art range; in cases where the claimed range overlaps or falls within the prior art range, a prima facie case of obviousness of the range exists. It would have been obvious to one having ordinary skill in the art to have selected the portion of the Young’s Modulus of the material in the range that corresponds to the claimed range. See MPEP 2144.05(I). Regarding claim 7, the method of injection molding, injection compression, transfer molding or embossing is a product-by-process limitation. Even though product-by-process claims are limited by and defined by the process, determination of patentability is based on the product itself. The patentability of a product does not depend on its method of production. If the product in the product-by-process claim is the same as or obvious from a product of the prior art, the claim is unpatentable even though the prior product was made by a different process and is therefore taught by Chen and Cohen (MPEP § 2113). The burden is on applicants to show product differences in product by process claims. Here, the limitations as to the method of forming the device by one of the specific methods is given minimal patentable weight. Further these methods are taught in paragraphs [0059]-[0060]. Regarding claim 8, Chen teaches the device or pillars, and the base wall section and ribs comprise a silicone rubber (paragraph [0051]). Regarding claim 16, modified Chen teaches the at least two rib elements prevent the inner wall surface from deforming when the device is received by the well of the microwell plate (the rib elements as added by Cohen would prevent the inner wall surface from deforming, Cohen, paragraph [0017], the examiner notes that the well of the microwell plate is not positively recited and therefore the limitations regarding the well of the microwell plate has minimal patentable weight). Regarding claim 17, the at least two rib elements increase the shear stress of the device (the rib elements as added by Cohen would increase the shear stress of the device, Cohen, paragraph [0017]) such that when the device is received by the well of the microwell plate the device is retained in the well of the microwell plate without an adhesive (the device would be able to be retained in the well without an adhesive, the examiner notes that the well of the microwell plate is not positively recited and therefore the limitations regarding the well of the microwell plate has minimal patentable weight). Claim(s) 9 is/are rejected under 35 U.S.C. 103 as being unpatentable over Chen and Cohen as applied to claim 7 above, and further in view of United States Application Publication No. 2019/0316068, hereinafter Chen2019. Regarding claim 9, Chen and Cohen teach all limitations of claim 7; however, they fail to teach the pillars are tapered towards the distal end with respect to the base section, and the distal end of the pillars are rounded or partly rounded at the interface between one or more sides walls of the pillar and the distal end of the pillar. Chen2019 teaches a device which have pillars that have a spherically shaped head that which permit even distribution of stress on the tissue, thus decreasing concentrations of stress at specific points of the tissue which could compromise the tissue's structural integrity (Chen2019, paragraph [0139]). It would have been obvious to one having ordinary skill in the art before the effective filing date of the claimed invention to have made the distal end of the pillars rounded (and therefore tapered) because it would permit even distribution of stress on the tissue, thus decreasing concentrations of stress at specific points of the tissue which could compromise the tissue's structural integrity (Chen2019, paragraph [0139]). Response to Arguments Applicant's arguments filed 10/2/2026 have been fully considered but they are not persuasive. In response to applicant's argument that Chen nor Cohen teach the device is configured to be received in a well of a microwell plate, a recitation of the intended use of the claimed invention must result in a structural difference between the claimed invention and the prior art in order to patentably distinguish the claimed invention from the prior art. If the prior art structure is capable of performing the intended use, then it meets the claim. Firstly, the examiner notes that the well of the microwell plate is not positively recited. Secondly, the structure described above for the device would be able to be received in a well of a microwell plate. The overall structure of Chen is in the shape of a microwell plate, however, only one of wells are considered to be the device as claimed and this device would be capable of being inserted into another well of another microwell plate. Regarding applicant’s argument that paragraph [0056] of Chen discloses that the height of the rib elements are less than or equal to the height of the wall section is found persuasive. In combination of paragraph [0056] of Chen and the rib elements as added by Cohen, the rib elements are equal to the height of the wall section, see figure 2 of Cohen. As such, the claim is rendered as obvious. Regarding applicant’s argument that Chen teaches a stiffness range and lists a series of stiffness ranges and the stiffness is not the same as the Youngs Modulus is not found persuasive. Chen teaches the values of the stiffness ranges and then states that the stiffness ranges is based upon the geometric dimensions of the cantilevers along with known values for the Young’s Modulus of the materials. Based upon this teaching in Chen, one of ordinary skill in the art would have recognized that there would still be an overlap of the Young’s Modulus of the pillars and it would have been obvious to one having ordinary skill in the art to have selected the portion of the Young’s Modulus of the material in the range that corresponds to the claimed range. See MPEP 2144.05(I). Further, Chen teaches that the material of the micro-cantilevers (pillars) are made from a silicone rubber which is the same material as the pillars in the instant application and as such it has been determined that where the claimed and prior art products are identical or substantially identical in structure or composition, or are produced by identical or substantially identical processes, a prima facie case of either anticipation or obviousness has been established. Absent persuasive evidence that the materials of the pillars are different are different, the prior art is considered to have the same properties with respect to Young’s Modulus as that is claimed. MPEP § 2112.01 (I-IV). In response to applicant's argument that the references fail to show certain features of the invention, it is noted that the features upon which applicant relies (i.e., that the pillars are tapered toward the distal end from the base section) are not recited in the rejected claim(s). Although the claims are interpreted in light of the specification, limitations from the specification are not read into the claims. See In re Van Geuns, 988 F.2d 1181, 26 USPQ2d 1057 (Fed. Cir. 1993). The claim only states that the pillar are tapered toward the distal end with respect to the base section. Therefore, any portion of the pillar which tapers would read on the instant claims. As applicant as stated that the pillars taper toward the distal end from the base section implies that the taper is from the bottom up and not just any portion. As the pillars as added by Chen2019 have a spherical head the spherical head is considered to taper toward the distal end with respect to the base as the spherical head gets a smaller cross-section as one gets to the end of the sphere, thereby being considered to taper and read on the instant claims. Conclusion Applicant's amendment necessitated the new ground(s) of rejection presented in this Office action. Accordingly, THIS ACTION IS MADE FINAL. See MPEP § 706.07(a). Applicant is reminded of the extension of time policy as set forth in 37 CFR 1.136(a). A shortened statutory period for reply to this final action is set to expire THREE MONTHS from the mailing date of this action. In the event a first reply is filed within TWO MONTHS of the mailing date of this final action and the advisory action is not mailed until after the end of the THREE-MONTH shortened statutory period, then the shortened statutory period will expire on the date the advisory action is mailed, and any nonprovisional extension fee (37 CFR 1.17(a)) pursuant to 37 CFR 1.136(a) will be calculated from the mailing date of the advisory action. In no event, however, will the statutory period for reply expire later than SIX MONTHS from the mailing date of this final action. Any inquiry concerning this communication or earlier communications from the examiner should be directed to MATTHEW D KRCHA whose telephone number is (571)270-0386. The examiner can normally be reached M-Th 7am-5pm. Examiner interviews are available via telephone, in-person, and video conferencing using a USPTO supplied web-based collaboration tool. To schedule an interview, applicant is encouraged to use the USPTO Automated Interview Request (AIR) at http://www.uspto.gov/interviewpractice. If attempts to reach the examiner by telephone are unsuccessful, the examiner’s supervisor, Maris Kessel can be reached at (571)270-7698. The fax phone number for the organization where this application or proceeding is assigned is 571-273-8300. Information regarding the status of published or unpublished applications may be obtained from Patent Center. Unpublished application information in Patent Center is available to registered users. To file and manage patent submissions in Patent Center, visit: https://patentcenter.uspto.gov. Visit https://www.uspto.gov/patents/apply/patent-center for more information about Patent Center and https://www.uspto.gov/patents/docx for information about filing in DOCX format. For additional questions, contact the Electronic Business Center (EBC) at 866-217-9197 (toll-free). If you would like assistance from a USPTO Customer Service Representative, call 800-786-9199 (IN USA OR CANADA) or 571-272-1000. /MATTHEW D KRCHA/Primary Examiner, Art Unit 1796
Read full office action

Prosecution Timeline

May 18, 2023
Application Filed
May 05, 2026
Non-Final Rejection mailed — §103
Oct 02, 2026
Response Filed
Nov 04, 2026
Final Rejection mailed — §103 (current)

Precedent Cases

Applications granted by this same examiner with similar technology

Patent 12789188
FLOW CELLS WITH DARK QUENCHER
4y 1m to grant Granted Nov 10, 2026
Patent 12791571
UNSUPERVISED TECHNIQUES FOR IDENTIFYING UNIVARIATE AND MULTIVARIATE ANOMALIES IN SCIENTIFIC INSTRUMENT RESULTS WITHIN A LABORATORY INFORMATION MANAGEMENT SYSTEM
3y 1m to grant Granted Nov 10, 2026
Patent 12782248
Infectious Disease Testing Method
3y 2m to grant Granted Nov 03, 2026
Patent 12766512
NUCLEIC ACID ANALYZER
3y 10m to grant Granted Oct 20, 2026
Patent 12769290
APPARATUSES, COMPUTER-IMPLEMENTED METHODS, AND COMPUTER PROGRAM PRODUCTS FOR PROCESSING MULTIPLE REPRESENTATIONS OF A PROCESSING PLANT
3y 7m to grant Granted Oct 20, 2026
Study what changed to get past this examiner. Based on 5 most recent grants.

Strategy Recommendation AI-generated — please review before filing

Get a prosecution strategy drawn from examiner precedents, rejection analysis, and claim mapping.
Typically takes 5-10 seconds — AI-generated, attorney review required before filing

Prosecution Projections

3-4
Expected OA Rounds
64%
Grant Probability
99%
With Interview (+35.5%)
3y 3m (~0m remaining)
Median Time to Grant
Moderate
PTA Risk
Based on 577 resolved cases by this examiner. Grant probability derived from career allowance rate.

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month